Ionis Pharmaceuticals (IONS) – Analyst Ratings
-
BofA Securities Upgrades Ionis Pharmaceuticals (IONS) to Neutral, 'Higher revenue potential'
-
Raymond James Starts Ionis Pharmaceuticals (IONS) at Strong Buy
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to IONS Stock Lookup